SEC Form 4 Reporting Owner · CIK 0001920574

Orbimed Capital Gp IX LLC

Director at Windward BIO Group Ag · Director at Braveheart Bio Inc · Director at Shattuck Labs Inc · +1 more

Bought (12 mo) +$54.9M
Sold (12 mo) —
Form 4 Filings 6
Companies 4
Filing Activity 2026-11-18 first filed 2024-11-05

Trading record

Open-market buys +$60.4M 4 filings
Open-market sales — 0 filings
Sales under a 10b5-1 plan — No open-market sales

Companies

Open-market shares bought and sold at each company, and the holding after the latest filing
CompanyRoleFilingsBoughtSoldNetHolding after latest filing
WWBWindward BIO Group Ag Insider tradingDirector11,176,471—+1,176,4717,097,715 2026-11-18
BRVEBraveheart Bio Insider tradingDirector11,940,000—+1,940,00011,901,826 2026-08-11
STTKShattuck Labs Insider tradingDirector36,306,127—+6,306,1276,306,127 2026-06-15
Lomond Therapeutics Insider tradingDirector1———2,677,256 2024-11-05

Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.

Insider Trading History

Company Type Value Filed View filing
WWB Windward BIO Group Ag Buy +$20,000,007 2026-11-18
BRVE Braveheart Bio Inc Buy +$34,920,000 2026-08-11
STTK Shattuck Labs Inc Derivative — 2026-06-15
STTK Shattuck Labs Inc - — 2026-06-10
STTK Shattuck Labs Inc Buy +$5,471,826 2025-09-03
— Lomond Therapeutics Holdings Inc Award — 2024-11-05